NIKA PHARMACEUTICALS, INC. (NIKA)

Every figure this model derived for NIKA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 2,932 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 9,942 AssetsCurrent 2026-06-30
current liabilities 340,624 LiabilitiesCurrent 2026-06-30
equity -330,682 StockholdersEquity 2026-06-30
revenue 0 Revenues 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up NIKA on one particular measure came for.

RatioValue
current ratio0.03
current ratio reported0.03
dilution pct2.53

What to be careful about

What this model itself distrusts about NIKA's figures. Written by the derivation as it ran, not added afterwards.